<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04653792</url>
  </required_header>
  <id_info>
    <org_study_id>preg2020micro</org_study_id>
    <nct_id>NCT04653792</nct_id>
  </id_info>
  <brief_title>Role Of Pregabalin To Decrease Postoperative Pain In Microdiscectomy</brief_title>
  <official_title>Role Of Pregabalin To Decrease Postoperative Pain In Microdiscectomy: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ziauddin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ziauddin University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effect of pregabalin in reducing the neuropathic&#xD;
      pain in postoperative patients who have undergone single level Microdiscectomy for prolapsed&#xD;
      intervetebral lumbar disc.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients were informed in detailed regarding the risk and complications and given written&#xD;
      and informed consent, coming to our clinics were assessed by one of the senior team members&#xD;
      of the spine, patient fulfilling the eligibility criteria were selected and included in the&#xD;
      study. One week before the surgery the patients who met the eligibility criteria were&#xD;
      randomized in a double-blind manner (participant and investigator) in a ratio of 1:1 into&#xD;
      Group-A (Pregabalin 7mg, twice daily) or Group-B (Placebo, twice daily). The pain scores were&#xD;
      recorded by VAS and Roland Morris score system on preoperative day compared to the scores on&#xD;
      the 1st week postoperative follow-up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 4, 2018</start_date>
  <completion_date type="Actual">April 17, 2020</completion_date>
  <primary_completion_date type="Actual">April 17, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change from preoperative pain score using a 10 point visual analog scale (VAS pain scale) at 1 week post surgery for PID</measure>
    <time_frame>Preoperative and one week postoperative</time_frame>
    <description>VAS pain scale is a validated, self-reported instrument assessing average pain intensity over the past 24 hours period. Possible scores being 0 (no pain) and 10 (worst possible pain). Change = (1 week post surgery - preoperative pain)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Pain, Nerve</condition>
  <condition>Prolapsed Intervertebral Disc</condition>
  <arm_group>
    <arm_group_label>Pregabalin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received Pregabalin 75mg capsule twice daily from preoperative day to 1 week postoperative</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregabalin Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants received Pregabalin placebo capsule matching Pregabalin twice daily from preoperative day to 1 week postoperative</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin 75mg</intervention_name>
    <description>75 mg capsule</description>
    <arm_group_label>Pregabalin</arm_group_label>
    <other_name>Lyrica (Pregabalin) 75mg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>75 mg</description>
    <arm_group_label>Pregabalin Placebo</arm_group_label>
    <other_name>Pregabalin placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients with severe CLBP and/or leg pain&#xD;
&#xD;
          -  Patients with static or dynamic leg pain&#xD;
&#xD;
          -  Patients with leg pain resulting from localized lumbar or lumbosacral segmental&#xD;
             instability&#xD;
&#xD;
          -  Spinal stenosis at levels L2-S1 or caused by isthmic spondylolisthesis (grade I and&#xD;
             II)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with previous lumbar surgery&#xD;
&#xD;
          -  Patients allergic to gabapentinoids&#xD;
&#xD;
          -  Patients with renal impairments&#xD;
&#xD;
          -  Patients who are already on opioids, benzodiazepines, barbiturates, ethanol (alcohol)&#xD;
&#xD;
          -  Patient presented with diabetes and other drugs that depress the central nervous&#xD;
             system&#xD;
&#xD;
          -  Patients who are already on ACE inhibitors as they may enhance the adverse/toxic&#xD;
             effect of Pregabalin.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shahzaib Riaz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ziauddin University hospital Karachi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sohail Rafi, FCPS</last_name>
    <role>Study Director</role>
    <affiliation>Ziauddin University Hospital Karachi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Ziauddin University Hospital Clifton Campus</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <zip>75600</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 27, 2020</study_first_submitted>
  <study_first_submitted_qc>December 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 4, 2020</study_first_posted>
  <last_update_submitted>December 3, 2020</last_update_submitted>
  <last_update_submitted_qc>December 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ziauddin University</investigator_affiliation>
    <investigator_full_name>Shahzaib Riaz Baloch</investigator_full_name>
    <investigator_title>Senior Resident, Orthopedics Department</investigator_title>
  </responsible_party>
  <keyword>Microdiscectomy</keyword>
  <keyword>Pregabalin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

